Literature DB >> 24002512

Optimal management of clinical stage I testis cancer: one size does not fit all.

Ronald de Wit1, George J Bosl.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24002512     DOI： 10.1200/JCO.2013.51.0479

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Testicular cancer: Optimal management of stage I seminoma in 2015.

Authors:  Guy C Toner
Journal:  Nat Rev Urol       Date:  2015-04-21       Impact factor: 14.432

2.  Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors.

Authors:  Deaglan J McHugh; Samuel A Funt; Deborah Silber; Andrea Knezevic; Sujata Patil; Devon O'Donnell; Stephanie Tsai; Victor E Reuter; Joel Sheinfeld; Brett S Carver; Robert J Motzer; Dean F Bajorin; George J Bosl; Darren R Feldman
Journal:  J Clin Oncol       Date:  2020-02-28       Impact factor: 44.544

Review 3.  Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors.

Authors:  Salim K Cheriyan; Marilin Nicholson; Ahmet M Aydin; Mounsif Azizi; Charles C Peyton; Wade J Sexton; Scott M Gilbert
Journal:  Transl Androl Urol       Date:  2020-01

4.  Mucinous cystic tumour of low malignant potential presenting in a patient with prior non-seminatous germ cell tumour.

Authors:  Daljeet Chahal; Mildred Martens; John Kinahan
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

Review 5.  Adjuvant Therapy for Stage IB Germ Cell Tumors: One versus Two Cycles of BEP.

Authors:  Robert A Huddart; Alison M Reid
Journal:  Adv Urol       Date:  2018-04-02

6.  Anaplastic variant of classical seminoma of the testis: northern Israel oncology center experience and brief review of literature.

Authors:  Moshe E Stein; Jamal Zidan; Tomer Charas; Karen Drumea; Rahamim Ben-Yosef
Journal:  Rambam Maimonides Med J       Date:  2014-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.